author-photo

Andreas Eisenmenger

German Cancer Research Center

10

Papers

178

Citations

Citation Trend

Filter By

Papers (5) Sort By

Journal Conference Others

Feasibility of real-time molecular profiling for patients with newly diagnosed glioblastoma without MGMT promoter hypermethylation—the NCT Neuro Master Match (N2M2) pilot study

2018 Neuro-oncology
Show All
- Source
- Cite
- Save
Citations (24)
Umbrella protocol for phase I/IIa trials of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without MGMT promoter methylation Neuro Master Match (N{superscript 2}M{superscript 2}).

2016
Show All
- Source
- Cite
- Save
Citations (0)
Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie.

2015 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (44)
629PLAPATINIB VERSUS LAPATINIB PLUS CAPECITABINE AS SECOND-LINE TREATMENT IN HER2-OVEREXPRESSING METASTATIC GASTRO-ESOPHAGEAL CANCER (GC): A RANDOMIZED PHASE II TRIAL OF THE ARBEITSGEMEINSCHAFT INTERNISTISCHE ONKOLOGIE (AIO)

2014 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Study on Lung Cancer Mortality Related to Radon, Quartz, and Arsenic Exposures in German Uranium Miners

2008 Journal of Toxicology and Environmental Health
Show All
- Source
- Cite
- Save
Citations (20)